As of Dec 02
| -0.05 / -2.16%|
The 2 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 3.75, with a high estimate of 4.00 and a low estimate of 3.50. The median estimate represents a +65.93% increase from the last price of 2.26.
The current consensus among 2 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.